BlackRock’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$227M Buy
6,256,145
+97,879
+2% +$3.56M ﹤0.01% 1541
2025
Q1
$223M Sell
6,158,266
-378,251
-6% -$13.7M ﹤0.01% 1529
2024
Q4
$275M Buy
6,536,517
+707,669
+12% +$29.8M 0.01% 1466
2024
Q3
$324M Buy
5,828,848
+225,496
+4% +$12.5M 0.01% 1368
2024
Q2
$230M Buy
5,603,352
+367,614
+7% +$15.1M 0.01% 1517
2024
Q1
$244M Sell
5,235,738
-2,662
-0.1% -$124K 0.01% 1505
2023
Q4
$251M Buy
5,238,400
+159,191
+3% +$7.61M 0.01% 1489
2023
Q3
$181M Buy
5,079,209
+12,182
+0.2% +$434K 0.01% 1589
2023
Q2
$234M Buy
5,067,027
+193,671
+4% +$8.93M 0.01% 1468
2023
Q1
$195M Buy
4,873,356
+536,513
+12% +$21.5M 0.01% 1550
2022
Q4
$201M Buy
4,336,843
+409,204
+10% +$19M 0.01% 1522
2022
Q3
$163M Buy
3,927,639
+330,055
+9% +$13.7M 0.01% 1623
2022
Q2
$215M Buy
3,597,584
+156,913
+5% +$9.36M 0.01% 1468
2022
Q1
$250M Sell
3,440,671
-43,981
-1% -$3.19M 0.01% 1496
2021
Q4
$293M Buy
3,484,652
+34,099
+1% +$2.87M 0.01% 1449
2021
Q3
$311M Sell
3,450,553
-41,388
-1% -$3.73M 0.01% 1366
2021
Q2
$333M Sell
3,491,941
-1,970,244
-36% -$188M 0.01% 1377
2021
Q1
$622M Buy
5,462,185
+174,709
+3% +$19.9M 0.02% 824
2020
Q4
$732M Buy
5,287,476
+478,279
+10% +$66.2M 0.02% 662
2020
Q3
$395M Sell
4,809,197
-101,469
-2% -$8.34M 0.01% 884
2020
Q2
$384M Buy
4,910,666
+347,135
+8% +$27.2M 0.02% 873
2020
Q1
$203M Sell
4,563,531
-169,553
-4% -$7.53M 0.01% 1160
2019
Q4
$202M Buy
4,733,084
+107,877
+2% +$4.61M 0.01% 1475
2019
Q3
$198M Buy
4,625,207
+208,992
+5% +$8.94M 0.01% 1410
2019
Q2
$280M Sell
4,416,215
-329,148
-7% -$20.9M 0.01% 1174
2019
Q1
$329M Buy
4,745,363
+268,551
+6% +$18.6M 0.01% 1046
2018
Q4
$195M Buy
4,476,812
+123,409
+3% +$5.37M 0.01% 1329
2018
Q3
$332M Sell
4,353,403
-35,947
-0.8% -$2.74M 0.01% 1073
2018
Q2
$337M Buy
4,389,350
+158,723
+4% +$12.2M 0.02% 1024
2018
Q1
$216M Buy
4,230,627
+498,740
+13% +$25.4M 0.01% 1301
2017
Q4
$173M Sell
3,731,887
-30,197
-0.8% -$1.4M 0.01% 1481
2017
Q3
$200M Buy
3,762,084
+264,493
+8% +$14.1M 0.01% 1334
2017
Q2
$217M Buy
3,497,591
+330,911
+10% +$20.6M 0.01% 1233
2017
Q1
$215M Buy
3,166,680
+3,163,586
+102,249% +$214M 0.01% 1220
2016
Q4
$218K Sell
3,094
-1,150
-27% -$81K ﹤0.01% 2041
2016
Q3
$301K Buy
4,244
+271
+7% +$19.2K ﹤0.01% 1908
2016
Q2
$194K Buy
3,973
+1,467
+59% +$71.6K ﹤0.01% 2084
2016
Q1
$159K Sell
2,506
-34,892
-93% -$2.21M ﹤0.01% 1752
2015
Q4
$4.2M Sell
37,398
-4,956
-12% -$556K 0.01% 877
2015
Q3
$4.08M Buy
42,354
+41,447
+4,570% +$3.99M 0.01% 831
2015
Q2
$93K Buy
907
+740
+443% +$75.9K ﹤0.01% 1774
2015
Q1
$10K Hold
167
﹤0.01% 2708
2014
Q4
$7K Hold
167
﹤0.01% 2922
2014
Q3
$9K Hold
167
﹤0.01% 2756
2014
Q2
$7K Sell
167
-10,700
-98% -$449K ﹤0.01% 2962
2014
Q1
$531K Buy
+10,867
New +$531K ﹤0.01% 1308